MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.5931
-0.0088
-1.46%
After Hours: 0.5862 -0.0069 -1.16% 18:20 08/10 EDT
OPEN
0.5980
PREV CLOSE
0.6019
HIGH
0.6000
LOW
0.5805
VOLUME
14.65K
TURNOVER
--
52 WEEK HIGH
1.650
52 WEEK LOW
0.4111
MARKET CAP
4.90M
P/E (TTM)
-0.2866
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (0803-0807)?
Weekly Report · 15h ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/03 12:06
Weekly Report: what happened at GLMD last week (0727-0731)?
Weekly Report · 08/03 09:12
Galmed Pharmaceuticals Wins Nasdaq Extension to Regain $1 Bid Price Compliance
TipRanks · 07/31 20:28
Galmed Unveils High-Exposure Orally Dispersible Aramchol Formulation for Parkinson’s Disease
TipRanks · 07/28 11:48
Galmed’s Aramchol ODF formulation shows positive results in Parkinson’s
TipRanks · 07/28 11:16
Galmed Pharma Announces Continued Advancement Of Aramchol As Potential Disease-Modifying Therapy For Parkinson's Disease, Reporting Significant Progress In Development Of New Aramchol ODF Formulation
Benzinga · 07/28 11:09
Galmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market
PR Newswire · 07/28 11:00
More
About GLMD
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.